New Key Statistics Module, Z-Score and F-Score
SZSE:002349 Key Ratios
Market Cap ¥ M | 5,943.52 |
Enterprise Value ¥ M | 4,858.94 |
P/E(ttm) | 26.75 |
PE Ratio without NRI | 26.65 |
Forward PE Ratio | -- |
Price/Book | 2.43 |
Price/Sales | 4.23 |
Price/Free Cash Flow | 24.44 |
Price/Owner Earnings | 42.79 |
Payout Ratio % | 0.33 |
Revenue (TTM) ¥ M | 1,436.00 |
EPS (TTM) ¥ | 0.28 |
Beneish M-Score | -2.5 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 12.00 |
EV-to-EBIT | 15.59 |
EV-to-EBITDA | 15.59 |
PEG | -- |
Shares Outstanding M | 814.18 |
Net Margin (%) | 15.91 |
Operating Margin % | 19.27 |
Pre-tax Margin (%) | 21.51 |
Quick Ratio | 5.71 |
Current Ratio | 6.69 |
ROA % (ttm) | 7.24 |
ROE % (ttm) | 9.15 |
ROIC % (ttm) | 13.74 |
Dividend Yield % | 1.26 |
Altman Z-Score | 13.05 |
SZSE:002349 Number of Guru Trades
SZSE:002349 Volume of Guru Trades
Gurus Latest Trades with SZSE:002349
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002349 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jinghua Pharmaceutical Group Co Ltd Insider Transactions
No Available Data